Adeno-associated Virus Gene Therapy With Cholesterol 24-Hydroxylase Reduces the Amyloid Pathology Before or After the Onset of Amyloid Plaques in Mouse Models of Alzheimer's Disease
Open Access
- 1 January 2010
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 18 (1) , 44-53
- https://doi.org/10.1038/mt.2009.175
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- ApoE Promotes the Proteolytic Degradation of AβNeuron, 2008
- Lovastatin inhibits amyloid precursor protein (APP) β‐cleavage through reduction of APP distribution in Lubrol WX extractable low density lipid raftsJournal of Neurochemistry, 2008
- Plaque-bearing mice with reduced levels of oligomeric amyloid-β assemblies have intact memory functionNeuroscience, 2007
- Cholesterol retention in Alzheimer's brain is responsible for high β- and γ-secretase activities and Aβ productionNeurobiology of Disease, 2007
- Regulation of central nervous system cholesterol homeostasis by the liver X receptor agonist TO-901317Neuroscience Letters, 2007
- Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptideNature Reviews Molecular Cell Biology, 2007
- Cyclohexanehexol inhibitors of Aβ aggregation prevent and reverse Alzheimer phenotype in a mouse modelNature Medicine, 2006
- The involvement of lipid rafts in Alzheimer's disease (Review)Molecular Membrane Biology, 2006
- Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid raftsThe Journal of cell biology, 2003
- Regulation of APP cleavage by α‐, β‐ and γ‐secretasesFEBS Letters, 2000